Scalp high‐frequency activity differentiates neonates with seizures from healthy neonates and indicates postneonatal epilepsy risk
Scalp HFA differentiates neonates with seizures from healthy neonates and may help identify those at higher risk for PNE. These findings support the potential use of scalp HFA as a potential biomarker for seizure monitoring and epilepsy risk stratification in neonates.
Authors
- Andrea Rüegger (ORCID: https://orcid.org/0000-0001-9953-8457)
- Georgia Ramantani (ORCID: https://orcid.org/0000-0002-7931-2327)
- Dorottya Cserpán (ORCID: https://orcid.org/0000-0002-7538-1931)
- Francesco Pisani (ORCID: https://orcid.org/0000-0002-6853-5605)
- Johannes Sarnthein (ORCID: https://orcid.org/0000-0001-9141-381X)
- Santo Pietro Lo Biundo (ORCID: https://orcid.org/0009-0004-3866-2189)
- Panagiota Karatza (ORCID: https://orcid.org/0009-0003-4377-7434)
Institutions
- Board of the Swiss Federal Institutes of Technology (CH)
- University Hospital of Zurich (CH)
- University Children's Hospital Zurich (CH)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Epilepsia
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1111/epi.70025
- Primary Topic
- Neonatal and fetal brain pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Vontobel-Stiftung